Physician profile
Matthew J Comstock
NPI 1174750749
$69,425.47
in general payments reported to CMS, 2019-2025
62 companies · $6,238 in 2025
The $6,238 reported for 2025 was more than what 85% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,877 · 2020: $11K · 2021: $16K · 2022: $6,348 · 2023: $18K · 2024: $3,083 · 2025: $6,238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $11K · Honoraria: $3,375 · Acquisitions: $1,225 · Travel and Lodging: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,925.00 |
| Food and Beverage | $10,715.47 |
| Honoraria | $3,375.00 |
| Acquisitions | $1,224.65 |
| Travel and Lodging | $526.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $37,514.84 | 2019-2025 | (6554) Periph Vasc Undiv, (9520) Igt Devices Undivided, IV Other |
| Cardinal Health 200 LLC | $5,253.22 | 2019-2020 | |
| Biotronik INC. | $4,903.36 | 2019-2023 | Biomonitor, Pulsar-18 T3, Passeo-18 |
| Abbott Laboratories | $4,053.59 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Diamondback Peripheral, Cardiomems |
| Cordis US Corp. | $3,173.02 | 2021-2025 | Radial 360, Saber, Mynxgrip |
| Boston Scientific Corporation | $1,757.92 | 2022-2025 | General - Therapies, Eluvia, Watchman Flx |
| Abiomed | $1,389.87 | 2019-2025 | Impella |
| Cardio Flow, INC. | $1,224.65 | 2025 | |
| Bard Peripheral Vascular, INC. | $1,196.04 | 2020-2025 | Rotarexs 6 F X 135 Cm, Venovo, Lutonix Drug Coated Balloon |
| Angiodynamics, INC. | $910.14 | 2020-2025 | Auryon Laser System 100-120 Vac, Venacure 1470 Pro, Alphavac |
| Janssen Pharmaceuticals, INC | $775.34 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $646.05 | 2022-2025 | Verquvo, Capvaxive |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $497.90 | 2020-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $440.07 | 2019-2024 | Farxiga |
| Reflow Medical INC | $406.69 | 2025 |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $373.38 | 2024-2025 | |
| Medtronic, INC. | $371.77 | 2024-2025 | Inceptiv, Turbohawk, Micra |
| Terumo Medical Corporation | $311.77 | 2020-2024 | Metacross Otw, Glidewire, Glidesheath Slender |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.43 | 2021-2024 | Jardiance |
| Endologix LLC | $289.97 | 2021 | |
| Amgen INC. | $272.41 | 2019-2024 | Repatha |
| Irhythm Technologies, INC. | $267.56 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Novartis Pharmaceuticals Corporation | $266.09 | 2019-2025 | |
| Silk Road Medical, INC. | $173.77 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| W. L. Gore & Associates, INC. | $171.61 | 2022-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Ekos Corporation | $170.61 | 2019 | |
| Biocompatibles, INC. | $165.72 | 2019 | |
| Organogenesis INC. | $162.78 | 2021-2022 | |
| Penumbra, INC. | $141.77 | 2023 | Indigo System |
| Medline Industries LP | $129.70 | 2023-2025 | |
| Celonova Biosciences, INC. | $125.91 | 2020 | |
| Smith+Nephew, INC. | $105.70 | 2021-2022 | |
| Cardiva Medical, INC. | $104.37 | 2021 | |
| Cleerly, INC. | $98.38 | 2024 | Cleerly Labs, Cleerly Ischemia |
| Atricure, INC. | $96.46 | 2022-2023 | |
| Inari Medical, INC. | $94.73 | 2022 | |
| Surmodics, INC. | $92.93 | 2025 | Pounce Venous Thrombectomy System, Sublime 014 Rx Pta Balloon Dilatation Catheter, Sublime Microcatheter, 018, 200cm, Straight |
| Novo Nordisk INC | $82.02 | 2022-2025 | Ozempic, Wegovy, Rybelsus |
| Amarin Pharma, INC. | $75.76 | 2020-2022 | |
| Veryan Medical Incorporated | $67.77 | 2021-2022 | |
| Edwards Lifesciences Corporation | $67.18 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $65.07 | 2021-2024 | Camzyos |
| Kerecis Limited | $55.07 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Cvrx, INC. | $53.62 | 2021 | |
| Vivaquant INC, Dba Rhythm Express | $52.91 | 2024 | Rhythm Express |
| Bayer Healthcare Pharmaceuticals INC. | $46.76 | 2023-2024 | |
| Lexicon Pharmaceuticals, INC. | $43.66 | 2023-2024 | Inpefa |
| Pfizer INC. | $41.66 | 2021 | |
| Asahi Intecc USA, INC. | $40.29 | 2024 | Peripheral Vascular |
| Impulse Dynamics (USA) INC. | $38.28 | 2024 | Optimizer |
| Baxter Healthcare | $37.13 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Cathworks, INC. | $27.31 | 2025 | Ffrangio |
| Infobionic, INC | $26.62 | 2022 | |
| Cardiovascular Systems INC. | $24.61 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $23.31 | 2025 | Evkeeza |
| Daiichi Sankyo INC. | $22.95 | 2023 | Injectafer |
| Cagent Vascular INC | $19.91 | 2025 | Serrantor |
| Kestra Medical Technology Services, INC. | $16.82 | 2024 | Assure Wcd |
| Cashflow Solutions, LLC | $16.49 | 2025 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Argon Medical Devices, INC. | $16.30 | 2021 | |
| Bardy Diagnostics, INC. | $15.22 | 2021 | |
| Lundbeck LLC | $13.23 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$20,000.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Comstock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.